HEAD AND NECK CANCERS- SQUAMOUS CELL
Clinical trials for HEAD AND NECK CANCERS- SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS- SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS- SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection combo shows promise against head and neck cancer
Disease control Recruiting nowThis early-phase study tests a new drug, VLPONC-01, injected directly into head and neck tumors to see if it's safe and can shrink tumors. About 41 adults with advanced head and neck cancer will receive the injection alone or with an immunotherapy drug (pembrolizumab). The goal i…
Matched conditions: HEAD AND NECK CANCERS- SQUAMOUS CELL
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:48 UTC
-
New blood test may predict head and neck cancer outcomes
Knowledge-focused Recruiting nowThis study looks at whether a special blood test can help predict how advanced head and neck cancer will progress. Researchers will collect blood samples from 30 patients with recurrent or metastatic head and neck cancer. They will analyze cancer cells and immune cells in the blo…
Matched conditions: HEAD AND NECK CANCERS- SQUAMOUS CELL
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 00:45 UTC